FibroBiologics Inc., a clinical-stage biotechnology company, will present at an exclusive live investor webinar on July 10, 2025. The event will feature CEO Pete O'Heeron discussing the company's fibroblast-based cell therapy platform aimed at treating chronic, inflammatory, and degenerative conditions. The presentation will cover their robust pipeline, including the lead candidate CYWC628 for diabetic foot ulcers, and upcoming clinical milestones. A live Q&A session will follow.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fibrobiologics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9490355-en) on July 07, 2025, and is solely responsible for the information contained therein.